New daily pill shows promise for weight loss in phase 2 trial

NCT ID NCT06828055

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested an experimental daily pill, VK2735, to help adults with obesity or overweight (plus a weight-related health issue) lose weight. About 280 participants took either the pill or a placebo for 13 weeks. The main goal was to see how much weight they lost and if the pill was safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Viking Clinical Site #100

    Indianapolis, Indiana, 46260, United States

  • Viking Clinical Site #101

    Clearwater, Florida, 33756, United States

  • Viking Clinical Site #102

    Port Orange, Florida, 32127, United States

  • Viking Clinical Site #103

    Knoxville, Tennessee, 37909, United States

  • Viking Clinical Site #104

    Austin, Texas, 78705, United States

  • Viking Clinical Site #105

    Lake Forest, California, 96230, United States

  • Viking Clinical Site #106

    San Antonio, Texas, 78229, United States

  • Viking Clinical Site #107

    Ocoee, Florida, 34761, United States

  • Viking Clinical Site #108

    Largo, Florida, 33777, United States

  • Viking Clinical Site #109

    City of Saint Peters, Missouri, 63303, United States

  • Viking Clinical Site #110

    Louisville, Kentucky, 40213, United States

  • Viking Clinical Site #111

    Peoria, Arizona, 85381, United States

  • Viking Clinical Site #112

    Kansas City, Missouri, 64131, United States

  • Viking Clinical Site #113

    Butte, Montana, 59701, United States

  • Viking Clinical Site #114

    Marrero, Louisiana, 70072, United States